Sonio’s Post

Prenatal Genetic Test Predicts Baby’s Traits as Early as 10 Weeks - HIT Consultant Title: Prenatal Genetic Test Predicts Baby's Traits as Early as 10 Weeks #Genetic Testing for Prenatal Care A new prenatal genetic test can predict a baby's traits as early as 10 weeks, offering valuable insights for parents and healthcare providers. This test goes beyond traditional screenings to provide detailed information about a baby's genetic makeup. #Non-Invasive Method The test is non-invasive, requiring only a blood sample from the mother. This makes it a safe and convenient option for prenatal care, eliminating the need for invasive procedures that carry potential risks. #Predicting Physical Traits By analyzing the baby's DNA, the test can predict physical traits such as eye color, hair color, and even potential health conditions ai.mediformatica.com #billiontoone #medical #about #testing #advanced #genetictesting #pregnancy #technology #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/493C8lE)

The Secret World Within: A Journey Through Prenatal Development | Aakash Khurana Witness the miracle of life unfold: The three stages of human development in the womb. #pregnancyjourney #prenataldevelopment #miracleoflife #growingbaby #babybump #germinalstage (weeks 1-2) #embryonicstage (weeks 3-8) #fetalstage (weeks 9-40) #1sttrimester #2ndtrimester #3rdtrimester Human development in the womb is a fascinating journey that takes place over approximately 40 weeks. There are three main stages of prenatal development: Germinal stage (weeks 1-2): This is the shortest stage, beginning at conception when a sperm fertilizes an egg. The fertilized egg, called a zygote, travels down the fallopian tube to the uterus. During this time, the zygote rapidly divides into many cells, forming a blastocyst. The blastocyst implants itself into the lining of the uterus, where it will continue to grow and develop. Embryonic stage (weeks 3-8): During this critical stage, the major organs and body systems of the baby begin to form. This is also the time when the embryo is most susceptible to birth defects. By the end of this stage, the embryo will have a beating heart, a developing brain and spinal cord, and limb buds that will eventually become arms and legs. Fetal stage (weeks 9-40): This is the longest stage of prenatal development, where the fetus grows and matures. The organs and systems that formed in the embryonic stage continue to develop and become more complex. The fetus also begins to move and respond to stimuli from the outside world. By the end of this stage, the fetus is fully formed and ready for birth. Each stage of prenatal development is essential for the healthy growth and development of the baby. If you are pregnant, it is important to take care of yourself and your baby by eating a healthy diet, getting enough exercise, and getting regular prenatal care. for more info: https://lnkd.in/gmxMcWay

𝐏𝐫𝐞𝐧𝐚𝐭𝐚𝐥 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭  Size highlights the market's growth potential, projecting a value of around USD 6.02 Billion by 2031, up from USD 4 Billion in 2023. This trajectory suggests a promising compound annual growth rate (CAGR) of 6.01% from 2024 to 2031. The Prenatal Screening Market focuses on medical tests and procedures used to assess the health of a fetus during pregnancy. These screenings help detect potential genetic disorders, chromosomal abnormalities, and other conditions that might affect the baby’s development. The market includes various screening methods such as blood tests, ultrasounds, and non-invasive prenatal testing (NIPT). 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gKyHG3ak Market #Trends: Non-Invasive Prenatal Testing (NIPT): NIPT is gaining popularity due to its accuracy and safety. This test analyzes cell-free fetal DNA in the mother’s blood, reducing the need for more invasive procedures like amniocentesis. Technological Advancements: Advances in genetic testing and ultrasound technology are improving the accuracy and reliability of prenatal screenings, leading to earlier and more precise detection of abnormalities. Rising Awareness: Increased awareness among expectant parents about the benefits of early screening and diagnosis is driving the demand for prenatal screening services. 📈 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧𝐬: Global Prenatal Screening Market: By #Company • Laboratory Corporation of America Holdings • Sequenom • Quest Diagnostics • Illumina • GeneDx • ARIOSA DIAGNOSTICS, INC. • Natera • Ravgen • Counsyl IT • NTD Eurofins • PREMAITHA HEALTH PLC • Prénatal Global Prenatal Screening Market: By #Type • First-Trimester Screening Tests • Second-Trimester Screening Tests • Third-Trimester Screening Tests • Diagnostic Tests Global Prenatal Screening Market: By #Application • Hospitals • Gynecology Clinics • Research Organizations 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞 𝐭𝐨 𝐆𝐞𝐭 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/gdbuXNKU ✅ 𝐅𝐨𝐥𝐥𝐨𝐰-Stringent Datalytics - Information Technology #PrenatalScreening #NIPT #MaternalHealth #GeneticTesting #FetalHealth #PregnancyCare #NonInvasiveTesting #EarlyDetection #DownSyndromeAwareness

✨ How Immunology Can Make or Break IVF Success! 🧬 Did you know your immune system 🛡️ plays a huge role in IVF? Here’s a fun look at how it works! 🌱 1️⃣ Immune System's Magic Trick 🧙♀️: During pregnancy, your body has to accept a tiny, genetically different embryo 👶. To do that, it shifts from a pro-inflammatory 🧨 to an anti-inflammatory 🧘♀️ mode, creating a welcoming environment! 2️⃣ NK Cells: The Double-Edged Sword ⚔️: Natural Killer (NK) cells 🦸♀️ are meant to protect you, but too many of them or too much action can harm the embryo 🥺. Finding balance ⚖️ is key to keeping everything safe. 3️⃣ Immune Deviations 👀: Studies show that higher NK activity and weird shifts in T cells can lower IVF success 📉. But if your immune system stays chill, you’ve got a much better chance 💪! 4️⃣ The Secret to Success 🔮: Women with fewer immune system hiccups tend to have higher pregnancy success rates 🎉. If your immune system is a little too wild 🦄, it might need some calming down to help out. 5️⃣ Immune-Friendly Treatments 💊: Understanding your immune profile means doctors can tailor your treatment! Special therapies 🩺 can help keep things on track for better IVF results. Immunology and IVF are the ultimate tag team! 👫 #IVFSuccess #Immunology #FertilityJourney #IVFTips #ReproductiveHealth #FertilityScience #EmbryoDevelopment #NKCells #FertilityAwareness #PregnancySupport #ImmuneHealth #FertilityImmunology #WomensHealth #FertilityCare #ScienceInFertility

The Harmony Non-Invasive Prenatal Test (NIPT) is a highly accurate screening test used during pregnancy to assess the risk of certain chromosomal conditions in the developing baby. Here's a brief overview: What is the Harmony NIPT? - Non-Invasive: The test uses a simple blood draw from the mother, making it safe for both the mother and the baby. - Cell-Free DNA: It analyzes cell-free DNA (cfDNA) from the placenta that circulates in the mother's blood. What Does It Screen For? - Common Chromosomal Conditions: The Harmony test screens for trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome). - Sex Chromosome Aneuploidies: It can also detect conditions related to the sex chromosomes, such as Turner syndrome and Klinefelter syndrome. - Microdeletions: The test includes screening for 22q11.2 deletion syndrome (DiGeorge syndrome). When Can It Be Performed? - Early Detection: The test can be performed as early as 10 weeks of gestation. Benefits of the Harmony NIPT: - High Accuracy: It provides highly accurate results with a low false-positive rate. - Peace of Mind: Offers expecting parents valuable information about their baby's health early in the pregnancy. - Non-Invasive: Unlike invasive procedures like amniocentesis, it poses no risk of miscarriage. How It Works: 1. Blood Draw: A blood sample is taken from the mother. 2. Laboratory Analysis: The sample is analyzed to detect cfDNA from the placenta. 3. Results: The results provide information about the likelihood of chromosomal conditions. The Harmony NIPT is a valuable tool for expecting parents, providing early and accurate information about their baby's health. #MedicalLaboratoryTechnology #Microbiology #Phlebotomy #LaboratoryTesting #DiagnosticTesting #HealthcareProfessional #MedicalTesting #ClinicalLaboratory #BiomedicalScience #HealthcareIndustry #MedicalScience #LaboratoryMedicine #ClinicalMicrobiology #InfectionControl #PhlebotomyTechnician #MedicalLabTechnician #MicrobiologyLab #ClinicalLab #HealthcareCareer #MedicalCareer #ScienceCareer #COVID19Testing #Virology #Bacteriology #Parasitology #MolecularDiagnosis #GeneticTesting #Cytology #Histopathology #Immunology #Serology

Exciting New Research Findings on IVF! I recently stumbled upon an insightful study published in Human Reproduction that thoroughly examines IVF's obstetric and perinatal risks, specifically emphasizing fresh blastocyst transfers. As someone who always considered IVF a relatively new and advanced technique, this research highlighted some critical points worth sharing. Key Takeaways from the Article: - Higher Risk of Placenta Previa: Singleton pregnancies after fresh blastocyst show a significantly higher risk of placenta previa compared to fresh cleavage stage transfers and spontaneous conceptions. - Increased Preterm Births: There is a notable increase in preterm births among singletons conceived after fresh blastocyst transfer. - Perinatal Complications: Fresh BT is associated with higher risks of very low birth weight and neonatal deaths. - Male/Female Ratio: The study found a higher male/female ratio in births following blastocyst transfer. - Monozygotic Twinning: The likelihood of same-sex twins after single embryo transfer is higher in blastocyst transfer than cleavage stage transfer. This comprehensive study, which analyzed data from Denmark, Norway, and Sweden, emphasizes the need for caution and meticulous planning in IVF treatments. The findings suggest that extended embryo culture to the blastocyst stage while optimizing embryo selection and increasing pregnancy rates may also introduce higher risks for certain complications. 💡 Why This Matters: Despite their advancements, our laboratory processes in IVF can significantly impact newborn outcomes. It's essential for healthcare professionals and prospective parents to be aware of these potential risks and to consider them in clinical decision-making. - - - - - - Full study: https://lnkd.in/eem72fn4 - - - - - - #IVF #Research #Healthcare #Fertility #Pregnancy #Obstetrics #PerinatalCare #BlastocystTransfer #CleavageStageTransfer #SpontaneousConception #HumanReproduction #ClinicalDecisionMaking #science

Importance of the First Trimester The first trimester of pregnancy is a crucial period marked by rapid development and significant milestones. Among the essential diagnostic tools in early prenatal care, the first trimester scan, typically conducted between 5 to 9 weeks gestation, offers invaluable insights into fetal growth, viability, and potential abnormalities.Purposes of the First Trimester Scan During this early stage of pregnancy, the first trimester scan serves multiple important purposes, providing reassurance to expectant parents and guiding clinical management decisions. Overview of the First Trimester Scan Here, we explore the significance of the first trimester scan and its role in optimizing maternal and fetal health. Confirmation of Pregnancy For many expectant parents, the first trimester scan represents the first tangible confirmation of pregnancy. By visualizing the gestational sac and embryonic structures, healthcare providers offer reassurance and confirmation of a developing pregnancy, alleviating anxieties and fostering a sense of connection with the unborn child. Dating and Viability Assessment Accurate dating of pregnancy is essential for optimal prenatal care. The first trimester scan enables precise determination of gestational age based on crown-rump length (CRL) measurements, facilitating accurate dating and estimation of the due date. Additionally, assessment of embryonic viability through visualization of fetal cardiac activity provides reassurance and identifies pregnancies at risk of miscarriage. Detection of Early Pregnancy Complications Despite the joy of pregnancy, early gestation can be fraught with potential complications. The first trimester scan allows for early detection of conditions such as ectopic pregnancy, gestational trophoblastic disease, and molar pregnancies, enabling prompt intervention and appropriate management to safeguard maternal health. Screening for Chromosomal Abnormalities In addition to dating and viability assessment, the first trimester scan plays a crucial role in early screening for chromosomal abnormalities, particularly through measurement of nuchal translucency (NT). An increased NT measurement may indicate an elevated risk of chromosomal anomalies such as Down syndrome, prompting further diagnostic testing and counseling for expectant parents. Assessment of Multiple Gestations Early ultrasound in the first trimester allows for early detection of multiple gestations, including twins and higher-order multiples. Visualization of separate gestational sacs and embryonic structures facilitates accurate diagnosis and management of multiple pregnancies, guiding prenatal care and delivery planning. #PrenatalCare #FirstTrimester #UltrasoundScan #PregnancyHealth #MaternalHealth #FetalDevelopment #Healthcare #Obstetrics #PregnancyCare #EarlyPregnancy

Case Report Spotlight : Sensitivity of NIPS in Detecting Trisomy 21 Excited to share a compelling case report from our clinic that underscores the remarkable sensitivity of Non-Invasive Prenatal Screening (NIPS) in detecting chromosomal abnormalities, particularly Trisomy 21. Patient Profile: A 37-year-old primi with no apparent fetal abnormalities other than the increased risk associated with advanced maternal age. Initial ultrasound at 12 weeks showed normal fetal growth and amniotic fluid levels. Diagnostic Journey: Given the maternal age factor, patient underwent NIPS at 13 weeks. Despite the reassuring ultrasound, NIPS indicated a high risk for Trisomy 21. Trisomy 21 is the most prevalent genetic disease worldwide and the common genetic cause of intellectual disabilities appearing in about 1 in 400-1500 newborns. This was confirmed via invasive prenatal testing and subsequent Fluorescent in Situ Hybridization (FISH) analysis, all of which pointed to Trisomy 21. Clinical Implications: Due to the high-risk pregnancy and potential complications, the pregnancy was discontinued.The skin scarping from the abortus fetus was further tested using chromosomal microarray analysis. This test showed that there was a gain of an additional copy of chromosome 21 at position p11.2 to q22.3 representing a complete gain of chromosome 21 reaffirming the diagnosis of Trisomy 21. Key Takeaways: This case underscores the exceptional sensitivity of NIPS in early pregnancy for detecting chromosomal abnormalities like Trisomy 21. NIPS serves as a valuable tool in estimating the risk of numerical chromosomal aneuploidies, facilitating early intervention and informed decision-making for expecting parents. Stay Tuned for More Insights! #NIPS #NonInvasivePrenatalScreening #Trisomy21 #DownSyndrome #PrenatalScreening #PrenatalTesting #EarlyDetection #HighSensitivity #FetalHealth #PregnancyCare #GeneticTesting #ExpectingMothers #PregnancyJourney #PrenatalCare #MedicalAdvancements #CaseReport #NIPS #Trisomy21 #PrenatalScreening #MedicalResearch Greenarray Genomics Research and Solutions

A new retrospective cohort study unveils an AI-powered model that can pinpoint ovulation with over 90% accuracy in natural-cycle frozen embryo transfers. When physicians aligned with the model’s recommendations, clinical pregnancy rates rose by as much as 8.7%—a clear indicator of how AI can revolutionize IVF and reduce guesswork in fertility care. Imagine combining this high-accuracy prediction with near- or at-home hormone testing. You’d simply upload results through a mobile app, bypassing daily trips to the clinic for blood draws and ultrasounds. This future-forward approach would not only democratize access to top fertility expertise (no matter where you live) but also reimagine the entire fertility ecosystem—fewer clinic visits, greater convenience, and a patient-centric experience. By evolving the traditional fertility model through AI and remote monitoring, we can offer more personalized, effective treatments and move one step closer to making the dream of parenthood accessible to all. https://lnkd.in/eypDjP-Q #fertilityos #fertility #ivfclinic #ai

Presagen sells IVF AI to Astec and more briefs - MobiHealthNews #PresagenSellsIVFAItoAstec Presagen, a healthcare AI company, has sold its AI technology for IVF to Astec, a global provider of IVF solutions. This acquisition will enhance Astec's offerings and improve patient outcomes in the field of assisted reproduction. #HealthcareAI #IVF #Astec #AIforRadiology Presagen has also developed AI technology for radiology, which has shown promising results in improving diagnostic accuracy and efficiency. This technology has the potential to revolutionize the way radiologists interpret medical images and make treatment decisions. #Radiology #DiagnosticAccuracy #PartnershipwithHealthEngine Presagen has partnered with HealthEngine, Australia's leading healthcare booking platform, to ai.mediformatica.com #aialgorithms #aisolutions #algorithms #feature #technology #advanced #core #market #pregnancy #well #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/40bUOPg)